Evidence map›Paper›PMID 37085636›Full record

ArticleJournal of computer-aided molecular design2023

TargIDe: a machine-learning workflow for target identification of molecules with antibiofilm activity against Pseudomonas aeruginosa.

João Carneiro, Rita P Magalhães, Victor M de la Oliva Roque, Manuel Simões, Diogo Pratas, Sérgio F Sousa

Open access · hybridAbstract read
In one paragraph

Article in Journal of computer-aided molecular design, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Anti-QS Strategies AgainstMicroorganisms · 2025
    Review
  2. Article
  3. Review
  4. Antibiofilm approaches as a new paradigm for treating infections.Progress in biomedical engineering (Bristol, England) · 2024
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

João Carneiro *Interdisciplinary Centre of Marine and Environmental Research, CIIMAR, University of Porto, Terminal de Cruzeiros do Porto de Leixões, Av. General Norton de Matos, s/n, Porto, 4450-208, Portugal. joaomiguelsov@gmail.com.ORCID 0000-0002-5153-2395
Rita P Magalhães *Faculty of Medicine, Associate Laboratory i4HB-Institute for Health and Bioeconomy, University of Porto, 4200-319, Porto, Portugal.ORCID 0000-0002-0156-2545
Victor M de la Oliva RoqueFaculty of Medicine, Associate Laboratory i4HB-Institute for Health and Bioeconomy, University of Porto, 4200-319, Porto, Portugal.
Manuel SimõesFaculty of Engineering, LEPABE Laboratory for Process Engineering, Environment, Biotechnology and Energy, University of Porto, Rua Dr. Roberto Frias, s/n, Porto, 4200-465, Portugal.ORCID 0000-0002-3355-4398
Diogo PratasInstitute of Electronics and Informatics Engineering of Aveiro, IEETA, University of Aveiro, Aveiro, Portugal.ORCID 0000-0003-1176-552X
Sérgio F SousaFaculty of Medicine, Associate Laboratory i4HB-Institute for Health and Bioeconomy, University of Porto, 4200-319, Porto, Portugal.ORCID 0000-0002-6560-5284
Universidade do Porto · PTUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial biofilms are a source of infectious human diseases and are heavily linked to antibiotic resistance. Pseudomonas aeruginosa is a multidrug-resistant bacterium widely present and implicated in several hospital-acquired infections. Over the last years, the development of new drugs able to inhibit Pseudomonas aeruginosa by interfering with its ability to form biofilms has become a promising strategy in drug discovery. Identifying molecules able to interfere with biofilm formation is difficult, but further developing these molecules by rationally improving their activity is particularly challenging, as it requires knowledge of the specific protein target that is inhibited. This work describes the development of a machine learning multitechnique consensus workflow to predict the protein targets of molecules with confirmed inhibitory activity against biofilm formation by Pseudomonas aeruginosa. It uses a specialized database containing all the known targets implicated in biofilm formation by Pseudomonas aeruginosa. The experimentally confirmed inhibitors available on ChEMBL, together with chemical descriptors, were used as the input features for a combination of nine different classification models, yielding a consensus method to predict the most likely target of a ligand. The implemented algorithm is freely available at https://github.com/BioSIM-Research-Group/TargIDe under licence GNU General Public Licence (GPL) version 3 and can easily be improved as more data become available.

Indexed as

Anti-Bacterial AgentsPseudomonas aeruginosaBiofilmsHumansMachine LearningMicrobial Sensitivity TestsWorkflowAnti-Bacterial AgentsBiofilmsLigand targetsMachine learningPseudomonas aeruginosa

Identifiers

PMID37085636
PMCPMC10232598
OpenAlexW4366722702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.